BCLC STAGE C HEPATOCELLULAR CARCINOMA
Clinical trials for BCLC STAGE C HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BCLC STAGE C HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for BCLC STAGE C HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to control advanced liver cancer
Disease control CompletedThis study tested a combination of two drugs, futibatinib and pembrolizumab, for people with advanced liver cancer that had spread and stopped responding to initial treatment. The goal was to see if the combination could help control the cancer's growth and extend the time before…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New combo therapy fights tough liver cancer
Disease control CompletedThis study compared two treatment approaches for advanced liver cancer that had spread into a major vein. Researchers tested whether adding a targeted liver chemotherapy (HAIC) to standard drug therapy (lenvatinib and PD-1 inhibitors) worked better than the standard drugs alone. …
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Sponsor: First Hospital of China Medical University • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
AI scans could predict best liver cancer treatment
Knowledge-focused CompletedThis study looked back at medical records and scans from 3,000 patients with advanced liver cancer who could not have surgery. Researchers used artificial intelligence (AI) to analyze their pre-treatment scans, trying to find patterns that predict whether a patient would live lon…
Matched conditions: BCLC STAGE C HEPATOCELLULAR CARCINOMA
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:47 UTC